New diabetes clinical trial: A Study Comparing HR17031 With Insulin Glargine in Patients With Type 2 Diabetes
Published on: March 17, 2025 at 11:00PM Conditions : Adult Patients With Type 2 Diabetes Uncontrolled on Oral Antidiabetic Drugs Interventions : Drug: HR17031 injection; Drug: insulin glargine Sponsors : Jiangsu HengRui Medicine Co., Ltd. Active, not recruiting https://ift.tt/BymtrKN